BURINEX

This brand name is authorized in Austria, Canada, France, Ireland, Malta, Netherlands, New Zealand, Singapore, South Africa.

Active ingredients

The drug BURINEX contains one active pharmaceutical ingredient (API):

1	Bumetanide UNII 0Y2S3XUQ5H - BUMETANIDE
	Bumetanide is a potent loop diuretic with a rapid onset and a short duration of action. The primary site of action is the ascending limb of the loop of Henle where it exerts inhibiting effects on electrolyte reabsorption, causing its diuretic and natriuretic action.
	Read more about Bumetanide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BURINEX Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03CA02	Bumetanide	C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CA Sulfonamides, plain
Discover more medicines within C03CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00728276, 00728284
FR	Base de données publique des médicaments	61834055, 67563415, 68232635
IE	Health Products Regulatory Authority	31596
MT	Medicines Authority	MA1303/00101, MA1303/00102, MA1303/00103, PI1438/04601A, PI908/13901A
NL	Z-Index G-Standaard	13277731
NL	Z-Index G-Standaard, PRK	26360
NZ	Medicines and Medical Devices Safety Authority	1816
SG	Health Sciences Authority	00718P, 01421P
ZA	Health Products Regulatory Authority	G/18.1/94, J/18.1/36